No definition available.
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
EFO MESH Endpoint Browser PheWeb
CD2_BENIGN_EAR_NASAL_SINUS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1476 |
4. Check minimum number of eventsNone |
1476 |
5. Include endpointsNone |
1476 |
6. Filter based on genotype QC (FinnGen only) |
1476 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D14
- Name in latin
- Neoplasma benignum auris mediae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
- Benign neoplasm of middle ear and respiratory system
- Benign neoplasm of middle ear and respiratory system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9658 | 4526 | 5061 |
| Only index persons | 8673 | 4172 | 4501 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.14 | 0.13 | 0.14 |
| Only index persons | 0.16 | 0.15 | 0.17 |
| Median age at first event (years) | |||
| Whole population | 53.85 | 54.43 | 53.29 |
| Only index persons | 52.85 | 53.43 | 52.31 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1476 | 692 | 784 |
| Unadjusted period prevalence (%) | 0.29 | 0.24 | 0.35 |
| Median age at first event (years) | 56.09 | 54.05 | 57.89 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1324
- Matched controls
- 13240
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
+∞
323.0
1167
*
DHB10
NOMESCO Finland
Excision of lesion of internal nose
434.1
225.7
220
6
DHA10
NOMESCO Finland
Biopsy of cavity of nose
96.2
218.2
238
30
UDH02
NOMESCO Finland
Rhinopharyngoscopy
13.2
206.1
391
408
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
10.2
126.0
266
317
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
146.4
114.2
120
9
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
11.2
98.4
195
201
UDM02
NOMESCO Finland
Sinoscopy
17.3
95.0
154
100
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
13.2
92.4
168
144
2120A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Nasal cavities, middle ear and accessory sinuses
+∞
89.6
85
*
J33.0
ICD-10 Finland
Polyp of nasal cavity
11.1
74.9
148
149
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
74.5
74.2
84
12
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
5.6
72.9
232
482
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
34.0
56.7
74
23
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.3
54.9
225
601
DHB20
NOMESCO Finland
Polypectomy of internal nose
16.1
54.1
89
59
R01AD08
ATC
fluticasone; nasal
2.7
51.5
476
2304
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
180.2
50.3
52
*
J33.8
ICD-10 Finland
Other polyp of sinus
9.9
49.8
103
112
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
49.3
47
*
DPA30
NOMESCO Finland
Sphenotomy
30.1
49.2
66
23
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
127.1
46.1
49
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
6.4
44.4
122
206
DHB40
NOMESCO Finland
Conchotomy
72.5
43.3
49
7
R01AD09
ATC
mometasone; nasal
2.2
41.7
649
3985
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
41.4
450
2318
DMB10
NOMESCO Finland
Radical maxillary antrotomy
31.2
40.8
54
18
21200
ICD-8 Finland
Benign neoplasm of respiratory system, Cavi nasi
+∞
35.6
34
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
35.5
586
3607
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
126.8
34.9
37
*
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
17.3
34.8
55
33
21202
ICD-8 Finland
Benign neoplasm of respiratory system, Sinus maxillaris
+∞
34.5
33
*
4256
FHL
Nasal or sinus tumor removal
+∞
34.5
33
*
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
17.2
33.5
53
32
DJW00
NOMESCO Finland
Removal of local lesion of nasal septum
335.1
33.0
33
*
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
7.8
32.7
77
104
J33.9
ICD-10 Finland
Nasal polyp, unspecified
13.5
32.1
56
43
ZXC10
NOMESCO Finland
Use of laser
8.0
30.8
71
93
DHB00
NOMESCO Finland
Excision of lesion of external nose
14.9
29.4
49
34
ZXE00
NOMESCO Finland
One hour or less
2.0
28.9
580
3762
J31.0
ICD-10 Finland
Chronic rhinitis
3.4
27.7
145
466
Z2221
NOMESCO Finland
Medical doctor
2.1
26.7
407
2349
R04.0
ICD-10 Finland
Epistaxis
3.2
26.3
148
500
DKW40
NOMESCO Finland
Ligature of artery of internal nose
51.1
25.3
30
6
DMB35
NOMESCO Finland
Endoscopic excision of neoplasm or another lesion from maxillary sinus
+∞
25.1
24
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
24.9
528
3436
R01AD12
ATC
fluticasone furoate; nasal
2.0
24.7
393
2296
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
24.4
674
4794
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
9.9
24.4
49
51
D36.7
ICD-10 Finland
Benign neoplasm: Other specified sites
49.3
24.3
29
6
B977, D140
ICD-10 Finland
NA
+∞
23.0
22
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.4
22.8
115
358
ZXD20
NOMESCO Finland
Day surgery
2.4
22.0
209
964
WX110
NOMESCO Finland
Local anesthesy
1.8
21.2
881
6996
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
21.2
300
1656
DNB40
NOMESCO Finland
Sublabial rhinotomy
111.8
20.6
22
*
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
33.1
20.2
26
8
ZXC95
NOMESCO Finland
Use of surgical navigator
10.0
20.2
40
41
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
36.4
19.9
25
7
H02AB06
ATC
prednisolone; systemic
1.7
19.6
622
4504
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
19.4
287
1607
ZXA05
NOMESCO Finland
Left side
1.9
19.3
368
2264
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
17.4
18.7
29
17
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
4.2
18.2
71
178
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
8.3
17.8
39
48
J32.1
ICD-10 Finland
Chronic frontal sinusitis
20.4
17.8
26
13
J34.2
ICD-10 Finland
Deviated nasal septum
3.2
17.4
92
298
WX002
NOMESCO Finland
Sedation and analgesia
1.9
17.0
285
1664
8070/3-C30.0
ICD-O-3
Squamous cell carcinoma, NOS, of nasal cavity
+∞
16.7
16
*
DHB50
NOMESCO Finland
Turbinoplasty
4.5
16.1
57
131
J01DB01
ATC
cefalexin; oral
1.7
15.9
1041
8985
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
6.1
15.8
43
73
J01CA04
ATC
amoxicillin; systemic
1.7
15.4
1009
8654
WX402
NOMESCO Finland
General anaesthesia
2.0
15.3
225
1245
DJA10
NOMESCO Finland
Biopsy of septum of nose
57.3
14.8
17
*
DPW99
NOMESCO Finland
Other operation on frontal or sphenoidal sinus
21.3
14.7
21
10
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
151.6
14.5
15
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
14.5
200
1079
DPB00
NOMESCO Finland
Partial excision of frontal sinus
30.4
13.9
18
6
ZXA00
NOMESCO Finland
Right side
1.7
13.7
377
2549
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.3
13.6
69
217
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
16.4
13.5
21
13
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.8
13.3
242
1441
ZXA10
NOMESCO Finland
Bilateral
1.8
13.3
253
1530
UDQ22
NOMESCO Finland
Microlaryngoscopy
8.6
13.3
28
33
J01AA02
ATC
doxycycline; systemic
1.6
13.2
984
8501
R01AD01
ATC
beclometasone; nasal
1.9
13.1
204
1150
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
13.0
554
4185
DPA20
NOMESCO Finland
Trephine of frontal sinus
22.8
12.9
18
8
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
17.5
12.5
19
11
DMB40
NOMESCO Finland
Excision of lesion of maxillary antrum trough lateral rhinotomy
+∞
12.5
12
*
4226
FHL
Posterior radical surgery and possible etmoidectomy
9.4
12.5
25
27
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
12.3
490
3630
N02BE01
ATC
paracetamol; systemic, rectal
1.7
12.2
1082
9646
R08
ICPC
Nose symptom/complaint other
3.5
12.1
56
165
J01FA10
ATC
azithromycin; systemic
1.5
12.0
682
5464
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
6.6
11.6
29
45
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
121.0
11.4
12
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
11.3
567
4396
J32.4
ICD-10 Finland
Chronic pansinusitis
5.0
10.9
34
70
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.2
10.6
55
178
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
10.3
218
1355
D38.58
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other respiratory organ
32.8
10.3
13
*
DMA10
NOMESCO Finland
Exploration of maxillary antrum
23.6
10.2
14
6
DQA10
NOMESCO Finland
Biopsy of larynx
10.1
10.0
19
19
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
3.5
9.8
44
128
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
9.7
438
3294
R06AX22
ATC
ebastine; oral
1.7
9.6
200
1234
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
4.4
9.6
33
76
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
100.7
9.4
10
*
R4110
NOMESCO Finland
Physiotherapy
1.6
9.4
324
2288
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
9.4
271
1835
DPB10
NOMESCO Finland
Partial excision of sphenoidal sinus
+∞
9.4
9
*
DPC35
NOMESCO Finland
Extensive endoscopic excision of lesion or neoplasm extending to more than one paranasal sinus
+∞
9.4
9
*
UDC00
NOMESCO Finland
Ear microscopy
2.1
9.2
105
524
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
9.1
348
2517
A02BC02
ATC
pantoprazole; systemic
1.4
9.0
783
6663
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
7.1
9.0
21
30
J33
ICD-10 Finland
Nasal polyp
10.1
9.0
17
17
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
8.9
256
1728
R51.81
ICD-10 Finland
Facial pain NOS
3.7
8.8
37
103
4222
FHL
Endonasal etmoidectomy
7.2
8.7
20
28
R06AE07
ATC
cetirizine; oral
1.4
8.6
490
3839
R03AC02
ATC
salbutamol; inhalant
1.4
8.6
608
4962
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
8.6
202
1291
J01.1
ICD-10 Finland
Acute frontal sinusitis
4.5
8.6
29
66
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
8.5
131
734
S01GX01
ATC
cromoglicic acid; ophthalmic
1.6
8.4
209
1354
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
8.4
406
3074
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
8.4
282
1975
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
6.8
8.4
20
30
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
8.3
61
248
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.9
8.3
122
671
A07AA02
ATC
nystatin; oral
2.2
8.3
85
407
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
5.0
8.2
25
51
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
8.2
438
3382
ZXD05
NOMESCO Finland
Urgent procedure
1.5
8.1
360
2679
4239
FHL
Other measure in this category
9.0
8.0
16
18
J32.8
ICD-10 Finland
Other chronic sinusitis
10.1
8.0
15
15
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
8.0
1105
10158
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.4
7.9
67
293
J01MA12
ATC
levofloxacin; systemic
1.6
7.8
226
1526
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
7.7
170
1065
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
7.7
377
2855
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
7.6
253
1764
M31.3
ICD-10 Finland
Wegener granulomatosis
11.9
7.6
13
11
WF002
NOMESCO Finland
Radical radiotherapy
2.3
7.6
68
307
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
10.1
7.5
14
14
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.8
7.5
46
169
B07.9
ICD-10 Finland
Verruca simplex
2.8
7.5
45
163
J01FF01
ATC
clindamycin; systemic
1.5
7.5
319
2347
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
7.3
804
6999
21208
ICD-8 Finland
Benign neoplasm of respiratory system, Nasi, loco multiplici
+∞
7.3
7
*
C72.2
ICD-10 Finland
Malignant neoplasm: Olfactory nerve
+∞
7.3
7
*
DJB10
NOMESCO Finland
Excision of septum of nose
+∞
7.3
7
*
Z3231
NOMESCO Finland
Registered nurse
1.5
7.3
329
2446
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
7.3
302
2209
KMAK
NOMESCO Finland
NA
1.4
7.2
577
4767
DCB00
NOMESCO Finland
Excision of lesion of middle ear
30.2
7.2
9
*
A02BC03
ATC
lansoprazole; oral
1.4
7.1
346
2608
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
7.1
191
1264
DJD20
NOMESCO Finland
Plastic repair of septum of nose
2.6
7.1
50
200
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.5
7.0
50
201
A02BC05
ATC
esomeprazole; systemic
1.4
7.0
467
3735
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
2.1
7.0
76
375
H65.3
ICD-10 Finland
Chronic mucoid otitis media
3.4
6.9
31
92
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.6
6.8
28
78
DKW99
NOMESCO Finland
Other procedures for control of epistaxis
9.4
6.8
13
14
R03DC03
ATC
montelukast; oral
1.6
6.8
173
1128
ZXC99
NOMESCO Finland
Other special technic in surgery
16.8
6.7
10
6
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.2
6.7
67
319
ZZC00
NOMESCO Finland
Graft of fascia
22.6
6.7
9
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
6.7
94
510
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.7
505
4116
50300
ICD-8 Finland
Chronic sinusitis, Maxillaris cum empyemate
6.5
6.6
16
25
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
6.6
183
1222
UDQ02
NOMESCO Finland
Direct laryngoscopy
4.8
6.5
20
42
R09
ICPC
Sinus symptom/complaint
2.0
6.5
79
405
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
6.9
6.5
15
22
G50.1
ICD-10 Finland
Atypical facial pain
3.5
6.5
28
81
Z3226
NOMESCO Finland
Physiotherapist
1.5
6.5
219
1528
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
6.5
87
465
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.9
6.5
93
511
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.2
6.5
65
308
DM1CD
NOMESCO Finland
Very extensive CT of paranasal sinuses and face area
70.2
6.4
7
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.0
6.4
34
116
N05CF01
ATC
zopiclone; oral
1.4
6.3
368
2860
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.3
531
4386
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
6.3
706
6095
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
11.1
6.3
11
10
J01DA01
ATC
[U] cefalexin; systemic
1.3
6.3
752
6560
Z01.2
ICD-10 Finland
Dental examination
1.4
6.3
441
3539
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
6.3
75
384
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.9
6.3
93
517
9522/3-C30.0
ICD-O-3
Olfactory neuroblastoma of nasal cavity
+∞
6.3
6
*
DM1BG
NOMESCO Finland
Paranasal sinuses and face area standard MRI examination with high intensity magnet
+∞
6.3
6
*
21209
ICD-8 Finland
Benign neoplasm of respiratory system, Nasi, NUD
+∞
6.3
6
*
B977, D141
ICD-10 Finland
NA
+∞
6.3
6
*
DPB20
NOMESCO Finland
Obliteration of frontal sinus
+∞
6.3
6
*
AAE05
NOMESCO Finland
Nasoendoscopic closure of cerebrospinal fluid fistula
+∞
6.3
6
*
J01
ICD-10 Finland
Acute sinusitis
2.2
6.2
57
262
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
6.2
588
4945
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.3
6.2
56
254
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.2
624
5299
J01FA09
ATC
clarithromycin; systemic
1.4
6.1
351
2716
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
6.1
341
2626
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
6.1
385
3030
DKW10
NOMESCO Finland
Packing of anterior cavity of nose
12.6
6.1
10
8
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
6.1
179
1209
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
6.1
93
521
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.6
6.1
40
155
H04.4
ICD-10 Finland
Chronic inflammation of lacrimal passages
10.1
6.0
11
11
UJH02
NOMESCO Finland
Anoscopy
2.2
6.0
55
252
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
6.0
40
156
G47.3
ICD-10 Finland
Sleep apnoea
1.5
6.0
253
1847
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
798
4705
2.52
65.14
2.8
2.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
271
1421
2.11
24.72
2.0
1.7
—
—
—
0
0
(4035726)
218
1063
2.23
23.85
1.5
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
307
1790
1.90
20.39
2.1
2.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
489
3361
1.68
18.21
3.4
3.2
e6/l
0.4
0.5
0.69
362
2585
(36304419) Bacteria [Presence] in Urine
476
3252
1.68
18.12
3.2
3.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
691
5202
1.62
17.81
5.0
5.0
g/l
35.3
35.4
0.10
644
4836
(3002256) Pathology report gross observation
262
1529
1.87
17.10
1.3
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
518
3681
1.63
16.59
3.5
3.3
e6/l
92.4
89.1
0.02
384
2887
(3018418) pH of Serum or Plasma
505
3571
1.63
16.47
4.5
4.0
ph
7.4
7.4
0.12
98
698
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
712
5465
1.59
16.47
6.6
6.2
mmol/l
1.2
1.2
1.01
668
4944
(3018095) Leukocytes [#/volume] in Urine
577
4246
1.59
15.79
4.1
3.7
e6/l
68.4
120.1
0.94
403
3091
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1086
9292
1.64
15.17
8.6
7.7
u/l
79.6
79.1
0.14
1021
8735
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
228
1356
1.81
13.81
2.6
2.7
umol/l
5.8
8.7
3.74
198
1200
(3044889) 12 lead EKG panel
1007
8547
1.56
13.71
4.3
3.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
547
4078
1.54
13.61
6.2
5.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
785
6356
1.50
13.00
6.3
6.3
umol/l
12.0
11.7
0.19
743
6040
(3033658) Prothrombin time (PT) actual/Normal
427
3042
1.57
12.87
4.5
3.9
%
89.6
88.8
0.32
418
2975
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
748
6015
1.49
12.69
7.4
7.0
mmol/l
1.2
1.2
0.86
625
5054
(3013707) Erythrocyte sedimentation rate by Westergren method
1027
8862
1.52
12.01
4.5
4.1
mm/h
13.2
12.4
0.83
957
8168
(3013650) Neutrophils [#/volume] in Blood by Automated count
835
6909
1.48
12.01
9.8
9.1
e9/l
4.3
4.2
1.04
715
6048
(40758558) Short blood count panel - Blood
418
3008
1.54
11.89
7.8
6.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
306
2061
1.61
11.55
3.1
2.8
e6/l
0.7
1.1
2.33
178
1205
(3001604) Monocytes [#/volume] in Blood
729
5917
1.46
11.29
6.8
5.8
e9/l
0.6
0.6
1.34
610
5107
(3006315) Basophils [#/volume] in Blood
730
5938
1.45
11.11
6.9
5.8
e9/l
0.0
0.0
0.12
610
5140
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
324
2236
1.58
10.98
2.9
3.1
mmol/l
2.4
2.5
0.08
274
1970
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
289
1946
1.60
10.86
3.3
2.9
e6/l
2.1
2.2
0.04
159
1094
(3002385) Erythrocyte distribution width [Ratio]
1108
9811
1.52
10.63
22.0
18.0
%
13.8
13.7
0.64
1090
9586
(3000494) Fungus identified in Specimen by Culture
227
1451
1.67
10.48
1.7
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
686
5558
1.44
10.43
7.0
6.0
%
3.0
2.9
1.10
634
5172
(3019069) Monocytes/100 leukocytes in Blood
688
5581
1.44
10.37
7.2
6.3
%
8.7
8.7
0.01
641
5214
(3019198) Lymphocytes [#/volume] in Blood
738
6071
1.43
10.26
6.9
5.9
e9/l
1.9
1.9
0.22
633
5344
(3031040) Bacteria [#/volume] in Urine by Automated count
912
7801
1.44
10.20
5.0
4.4
e6/l
3301.9
1777.5
—
8
113
(3013115) Eosinophils [#/volume] in Blood
745
6143
1.43
10.20
7.1
6.1
e9/l
0.2
0.2
1.16
642
5403
(3021589) Normoblasts [#/volume] in Blood
656
5293
1.43
10.09
10.8
9.8
e9/l
0.0
0.0
0.44
521
4348
(3002030) Lymphocytes/100 leukocytes in Blood
699
5714
1.42
9.95
7.1
6.1
%
27.0
27.4
0.45
645
5319
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
180
1107
1.71
9.57
2.9
2.4
u/l
33.5
38.4
0.45
150
943
(3022096) Basophils/100 leukocytes in Blood
664
5409
1.41
9.49
7.1
6.0
%
0.7
0.7
0.05
616
5043
(3000850) Epithelial cells [#/volume] in Urine
355
2576
1.50
9.38
2.6
2.6
e6/l
4.1
5.3
1.57
297
2279
(3026782) Osmolality of Urine
338
2440
1.50
9.13
3.1
2.7
mosm/kgh2o
549.2
553.2
0.12
281
2086
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
683
5645
1.39
8.71
3.9
4.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1284
11893
1.61
8.64
18.9
14.8
mg/l
23.4
25.0
1.10
1078
9444
(3018010) Neutrophils/100 leukocytes in Blood
680
5623
1.39
8.61
7.0
5.9
%
57.3
57.6
0.26
630
5258
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
27
75
3.65
8.58
1.3
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
514
4065
1.41
8.44
3.2
3.4
mmol/l
2.4
2.4
0.17
459
3540
(3012095) Magnesium [Moles/volume] in Serum or Plasma
277
1958
1.51
8.20
4.2
3.4
mmol/l
0.8
0.8
0.17
258
1839
(3023368) Bacteria identified in Blood by Culture
442
3425
1.41
8.09
4.9
4.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
611
5004
1.38
8.03
2.1
2.0
pmol/l
94.8
94.0
0.16
311
2633
(3013826) Glucose [Moles/volume] in Serum or Plasma
830
7142
1.37
7.98
5.5
5.0
mmol/l
6.8
6.8
0.01
782
6711
(3023419) Bacteria identified in Sputum by Culture
42
160
2.67
7.92
2.4
2.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1318
12348
1.63
7.72
21.2
17.2
mmol/l
139.6
139.7
0.68
1302
12021
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1179
10788
1.46
7.71
5.1
4.6
mu/l
1.9
2.2
1.10
1090
9809
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1227
11318
1.50
7.68
17.1
13.7
ml/min/173m2
80.3
79.8
0.30
1047
9389
(3023103) Potassium [Moles/volume] in Serum or Plasma
1319
12383
1.61
7.37
21.3
17.3
mmol/l
4.0
4.0
1.66
1300
12039
(3037467) Urinalysis macro (dipstick) panel - Urine
927
8180
1.36
7.23
4.8
4.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
209
1428
1.54
7.20
3.9
4.1
u/l
249.7
248.8
0.03
195
1354
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
999
8924
1.37
7.17
4.3
3.9
pmol/l
14.8
14.9
0.38
919
8066
(3011397) Hemoglobin [Presence] in Urine by Test strip
353
2680
1.42
7.12
4.2
3.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
129
790
1.69
6.96
1.3
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
94
526
1.84
6.91
2.8
1.4
u/ml
10.9
10.6
—
9
14
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
57
268
2.17
6.83
1.5
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
140
883
1.65
6.76
1.6
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
476
3845
1.35
6.49
2.5
2.5
u/l
57.9
57.4
0.10
443
3564
(3005719) IgG [Mass/volume] in Serum or Plasma
143
919
1.62
6.41
2.7
2.8
g/l
10.4
10.7
0.42
129
840
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
108
645
1.73
6.40
10.2
10.4
mmol/l
24.7
24.4
0.32
99
608
(3036481) Cortisol [Moles/volume] in Serum or Plasma
162
1077
1.57
6.30
3.2
2.2
nmol/l
365.1
366.8
0.04
156
986
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
98
574
1.76
6.22
4.0
3.7
mmol/l
24.4
24.1
0.45
93
518
(3044640) Blood type and Crossmatch panel - Blood
472
3833
1.34
6.14
2.4
2.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
600
5053
1.32
6.03
10.7
9.9
inr
1.3
1.3
0.09
174
1486
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
573
4796
1.32
6.01
2.4
2.2
nmol/l
77.5
77.1
0.11
515
4276
(3000991) Gas panel - Venous blood
156
1040
1.56
5.99
9.3
8.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
200
1426
1.47
5.58
7.9
8.1
kpa
5.1
5.1
0.11
191
1361
(3027801) Oxygen [Partial pressure] in Arterial blood
200
1427
1.46
5.56
7.9
8.1
kpa
13.0
12.0
1.30
190
1364
(40761511) CBC panel - Blood by Automated count
1308
12389
1.49
5.55
16.1
14.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
61
322
1.93
5.42
1.3
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
454
3722
1.32
5.40
2.0
2.2
u/l
188.6
228.0
0.67
428
3503
(40768797) Stomach Pathology biopsy report
230
1699
1.42
5.31
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
31
125
2.51
5.30
4.2
3.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1336
12729
1.52
5.29
12.2
10.6
u/l
26.2
26.7
0.72
1298
12263
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
62
334
1.89
5.19
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
62
334
1.89
5.19
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
65
357
1.86
5.14
2.7
3.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
198
1432
1.44
5.13
8.0
8.1
mmol/l
1.3
1.2
0.19
157
1119
(46235355) HIV 1 and 2 tests - Meaningful Use set
235
1756
1.40
5.07
1.7
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1160
10809
1.34
5.02
20.0
15.7
%
40.3
39.9
1.20
841
7591
(42529406) Shigella sp [Presence] in Stool by Culture
62
338
1.87
5.02
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
85
510
1.71
5.00
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
234
1754
1.40
4.96
1.5
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
194
1410
1.43
4.89
1.9
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
298
2332
1.35
4.82
4.4
3.8
ng/l
281.5
376.5
0.38
230
1846
(3048689) Calprotectin [Mass/mass] in Stool
185
1337
1.44
4.81
2.1
2.3
ug/g
152.2
138.6
0.22
148
1062
(3035350) Ketones [Presence] in Urine by Test strip
662
5776
1.26
4.68
4.3
3.7
estimate
0.0
0.0
0.00
134
1110
(3003458) Phosphate [Moles/volume] in Serum or Plasma
217
1623
1.40
4.65
5.2
5.8
mmol/l
1.0
1.0
0.02
201
1503
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
148
1033
1.48
4.61
2.9
2.9
ng/l
208.0
205.8
0.02
136
944
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
191
1400
1.42
4.60
1.9
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
248
1900
1.37
4.59
2.5
2.1
s
30.2
29.8
0.36
241
1839
(3000492) Spirometry study
164
1173
1.45
4.51
1.6
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1374
13236
1.55
4.42
26.9
21.7
e9/l
247.6
247.3
0.06
1352
12889
(3001122) Ferritin [Mass/volume] in Serum or Plasma
577
4977
1.26
4.42
3.3
2.8
ug/l
152.6
141.0
0.24
541
4559
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
376
3077
1.30
4.40
2.5
2.2
mg/l
3.1
3.0
0.08
326
2603
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
20
71
2.84
4.39
2.2
2.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
1374
13239
1.55
4.38
26.8
21.6
fl
91.0
91.2
0.60
1366
13025
(3026361) Erythrocytes [#/volume] in Blood
1374
13242
1.54
4.34
26.9
21.6
e12/l
4.5
4.5
0.15
1347
12855
(3000963) Hemoglobin [Mass/volume] in Blood
1374
13245
1.54
4.30
27.1
21.8
g/l
135.2
135.8
0.67
1366
13029
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
178
1305
1.41
4.28
3.8
3.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
465
3922
1.27
4.27
3.5
3.3
u/l
34.4
34.1
0.03
442
3728
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
784
7024
1.25
4.25
2.9
2.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
1373
13241
1.53
4.20
26.8
21.5
pg
30.3
30.4
1.52
1365
13025
(3026389) Candida sp identified in Specimen by Organism specific culture
33
153
2.18
4.20
1.1
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1373
13244
1.53
4.16
27.0
21.7
e9/l
7.0
6.7
2.31
1347
12855
(4062490)
25
103
2.45
4.14
2.2
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
665
5861
1.25
4.14
4.3
3.7
estimate
0.0
0.0
1.08
133
1081
(3024980) IgG subclass 4 [Mass/volume] in Serum
36
174
2.10
4.13
2.4
1.6
g/l
0.8
0.8
0.06
28
131
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
220
1682
1.36
4.12
2.7
2.6
%
20.9
23.1
1.70
194
1441
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
34
162
2.12
4.05
1.2
1.3
nmol/l
0.6
0.7
0.27
34
153
(3026493) Urate [Moles/volume] in Serum or Plasma
389
3230
1.28
4.02
3.1
2.8
umol/l
6305.8
6289.9
0.00
332
2794
(3017143) Hepatitis C virus Ab [Presence] in Serum
166
1218
1.41
3.98
1.5
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
212
1620
1.36
3.98
27.2
25.7
inr
1.4
1.4
0.19
36
223
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
23
93
2.50
3.97
1.3
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1180
11127
1.30
3.96
6.3
5.9
mmol/mol
40.1
40.1
0.08
1106
10281
(3003327) Ova and parasites identified in Stool by Light microscopy
58
335
1.76
3.96
1.5
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1230
11669
1.32
3.91
4.9
4.6
mmol/l
6.0
6.0
0.29
1148
10581
(3024928) Oxygen saturation in Venous blood
49
270
1.84
3.90
2.5
2.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
655
5791
1.24
3.88
5.7
5.0
estimate
0.0
0.0
0.00
140
1125
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
866
7887
1.24
3.88
3.2
3.2
u/l
46.4
51.9
1.31
812
7343
(3016502) Oxygen saturation in Arterial blood
173
1285
1.39
3.87
8.6
8.6
%
95.6
95.6
0.08
165
1237
(3024139) IgG subclass 3 [Mass/volume] in Serum
24
101
2.40
3.82
2.1
1.3
g/l
0.3
0.4
0.22
17
66
(3027135) IgG subclass 1 [Mass/volume] in Serum
24
101
2.40
3.82
2.1
1.3
g/l
7.0
7.2
0.10
17
68
(3028192) IgG subclass 2 [Mass/volume] in Serum
24
101
2.40
3.82
2.1
1.3
g/l
3.4
2.8
0.77
17
67
(3028026) IgM [Mass/volume] in Serum or Plasma
108
736
1.50
3.81
1.7
1.8
g/l
1.4
1.4
0.08
95
679
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
32
153
2.12
3.80
1.2
1.3
—
—
—
0
0
(3012544) pH of Venous blood
162
1198
1.40
3.72
4.1
3.6
—
7.4
—
0
5
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
193
1470
1.36
3.70
1.5
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
253
2009
1.31
3.66
2.0
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
323
2650
1.28
3.64
1.9
1.7
mg/l
1.3
1.2
0.30
267
2037
(3022948) Iron [Moles/volume] in Serum or Plasma
245
1939
1.32
3.63
2.6
2.5
umol/l
11.7
13.0
2.02
229
1792
(3002173) Hemoglobin [Mass/volume] in Arterial blood
161
1195
1.39
3.62
9.1
9.0
g/l
119.7
121.6
0.50
154
1153
(3004716) Salmonella sp identified in Stool by Organism specific culture
83
542
1.56
3.57
1.3
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
382
3210
1.26
3.52
1.7
1.7
mmol/l
1.5
1.4
0.86
318
2664
(3004789) Transferrin [Mass/volume] in Serum or Plasma
226
1780
1.32
3.46
2.6
2.5
g/l
2.3
2.3
0.09
210
1652
(3014007) Fractional oxyhemoglobin in Arterial blood
112
786
1.46
3.44
10.3
9.7
%
93.6
93.8
0.21
112
779
(3042111) Morphology [Interpretation] in Bone marrow Narrative
40
216
1.88
3.42
1.4
1.6
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
111
782
1.45
3.35
10.3
9.7
%
0.6
0.7
0.53
111
776
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
104
724
1.47
3.34
1.5
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
183
1406
1.34
3.32
2.3
2.6
%
1.8
1.8
0.05
169
1259
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
45
255
1.79
3.32
1.5
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
352
2952
1.25
3.28
2.4
2.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
60
372
1.64
3.22
1.5
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
38
207
1.86
3.19
1.1
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
29
144
2.03
3.17
1.0
1.0
u/ml
0.7
4.0
—
7
36
(3007164) IgA [Mass/volume] in Serum or Plasma
270
2203
1.28
3.16
1.6
1.4
g/l
2.4
2.5
0.36
160
1362
(3023323) Follitropin [Units/volume] in Serum or Plasma
60
375
1.63
3.13
1.4
1.4
iu/l
30.5
27.4
0.30
47
316
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
97
678
1.46
3.07
10.5
11.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
251
1.73
2.91
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
251
1.73
2.91
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
310
2596
1.25
2.90
5.2
4.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
20
89
2.26
2.87
1.3
1.2
u/ml
0.4
0.8
—
10
44
(3012501) Base excess in Blood by calculation
47
284
1.68
2.82
3.1
5.0
mmol/l
2.6
2.5
0.13
32
194
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
47
2.78
2.82
3.7
2.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
45
269
1.69
2.81
1.8
2.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
151
1158
1.34
2.80
4.2
3.5
mmol/l
2.0
2.0
0.07
131
922
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
28
145
1.95
2.76
1.1
1.3
nmol/l
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
104
2.13
2.75
1.1
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
36
203
1.79
2.75
1.5
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
23
111
2.09
2.73
1.3
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
22
105
2.11
2.69
2.0
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
172
1354
1.31
2.66
1.2
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
133
1.97
2.66
1.8
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
133
1010
1.35
2.64
3.5
3.9
mmol/l
1.2
1.2
0.36
120
872
(3021387) Prolactin [Units/volume] in Serum or Plasma
50
313
1.62
2.64
2.1
1.6
mu/l
278.5
284.9
0.07
43
282
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
16
67
2.40
2.63
1.7
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
16
67
2.40
2.63
1.7
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
47
291
1.64
2.59
1.6
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
52
331
1.59
2.57
1.8
2.1
mg/l
10.5
11.9
0.75
47
304
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
11
5.47
2.54
1.2
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1235
11872
1.25
2.53
4.7
4.5
mmol/l
4.5
4.6
2.12
1160
10946
(3009214) Lutropin [Units/volume] in Serum or Plasma
45
278
1.64
2.51
1.2
1.4
u/l
10.4
9.1
0.22
35
225
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1226
11783
1.24
2.47
4.6
4.4
mmol/l
1.4
1.4
3.84
1143
10788
(1002224) Polysomnography panel
69
473
1.48
2.46
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
31
174
1.80
2.43
1.1
1.1
u/ml
1.5
1.9
0.12
17
77
(3003888) Timothy IgE Ab [Units/volume] in Serum
28
153
1.85
2.39
1.0
1.0
u/ml
4.5
5.1
0.10
15
76
(3007566) Smooth muscle Ab [Titer] in Serum
51
330
1.56
2.37
1.1
1.2
titre
48.3
84.2
—
6
24
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
17
4.13
2.36
1.3
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
17
4.13
2.36
1.3
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
17
4.13
2.36
1.3
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
416
3658
1.19
2.35
3.0
3.0
ng/l
1199.7
1394.8
0.63
366
3129
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
47
300
1.59
2.32
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
101
751
1.37
2.32
1.2
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
136
1059
1.31
2.30
2.3
2.8
e9/l
76.1
70.0
1.04
102
824
(4010399)
114
866
1.34
2.29
1.5
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
38
232
1.65
2.25
1.5
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
45
287
1.59
2.24
1.2
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
29
3.12
2.22
1.3
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
127
985
1.32
2.22
2.2
2.3
nmol/l
12.7
13.0
0.18
113
873
(3026008) Bacteria identified in Urine by Culture
403
3550
1.19
2.22
3.4
3.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
9
5.57
2.21
1.4
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
27
150
1.81
2.21
1.0
1.0
u/ml
0.5
1.9
0.94
13
63
(3021960) Folate [Moles/volume] in Serum or Plasma
334
2895
1.20
2.20
1.6
1.6
nmol/l
19.8
20.5
0.39
298
2460
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
89
655
1.38
2.19
2.6
3.4
pmol/l
4.3
4.5
1.16
79
572
(3045414) Leukocytes [Presence] in Urine
74
528
1.42
2.18
1.7
1.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
73
520
1.42
2.17
2.1
2.0
u/l
36.5
39.2
0.65
64
461
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
81
588
1.40
2.16
2.0
1.8
g/l
1.6
1.6
0.29
68
514
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
19
3.70
2.15
1.0
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1251
12097
1.22
2.09
5.3
5.0
mmol/l
2.7
2.7
1.94
1172
11078
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
123
964
1.30
2.01
1.9
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
29
170
1.72
2.01
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
123
966
1.30
1.99
3.0
2.7
ml/min/173m2
67.1
64.7
0.24
53
400
(3019060) Gas panel - Arterial blood
109
844
1.31
1.95
4.1
5.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
164
1.72
1.95
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
38
242
1.59
1.94
2.9
3.6
%
58.0
57.4
0.14
38
242
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1182
11396
1.19
1.89
4.1
4.0
mmol/l
1.4
1.3
2.60
1088
10377
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
450
1.42
1.88
2.7
2.5
g/l
10.6
10.6
0.01
53
385
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
83
622
1.35
1.86
2.4
2.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
30
182
1.66
1.86
2.3
2.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
46
2.40
1.85
1.1
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
101
1.89
1.81
1.5
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
23
3.05
1.80
1.3
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
19
102
1.87
1.76
1.4
1.1
titre
134.0
145.3
—
5
17
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
67
2.10
1.76
1.9
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
18
95
1.91
1.75
2.4
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
18
95
1.91
1.75
1.9
2.0
%
12.9
10.6
0.82
18
95
(1616796) Gas panel - Central venous blood
42
281
1.51
1.75
2.2
4.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
36
233
1.56
1.74
2.9
3.3
e9/l
4.2
4.4
0.18
36
233
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
62
449
1.40
1.73
2.5
2.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
129
1040
1.26
1.72
4.0
3.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
129
1041
1.26
1.71
2.6
2.8
g/l
64.9
66.5
1.86
119
949
(3036670) Protein [Mass/volume] in Synovial fluid
0
46
0.00
1.71
0.0
1.2
—
36.5
—
0
26
(3004588) Protein electrophoresis panel - Serum or Plasma
110
871
1.28
1.70
2.6
2.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
126
1015
1.26
1.70
4.2
4.3
%
0.9
0.8
0.15
45
307
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
195
1.60
1.69
1.3
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
137
1117
1.25
1.67
6.9
7.6
mmol/l
10.0
9.9
0.06
131
1072
(40757373) Influenza virus identified in Isolate
7
25
2.81
1.65
1.6
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
26
158
1.66
1.63
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
107
851
1.28
1.61
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
43
2.33
1.60
2.3
2.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
112
897
1.27
1.60
1.4
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
135
1106
1.24
1.59
2.0
2.5
ug/l
7.9
7.2
0.13
120
989
(3002179) Metamyelocytes/100 leukocytes in Blood
115
925
1.26
1.58
3.8
4.1
%
0.7
0.6
0.16
28
226
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
26
2.70
1.58
1.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
35
231
1.53
1.58
1.3
1.2
u/ml
57.7
48.3
—
5
17
(40768441) Liver Pathology biopsy report
18
99
1.83
1.57
1.4
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
108
864
1.27
1.56
1.9
1.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
49
348
1.42
1.55
1.6
1.5
ug/g
262.8
286.1
0.37
34
200
(40767503) Oxygen content in Capillary blood by calculation
40
273
1.48
1.55
2.2
2.6
%
15.5
16.2
0.26
13
143
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
221
1907
1.19
1.54
1.3
1.2
u/ml
8.2
11.5
0.39
71
734
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
38
257
1.49
1.54
4.3
5.4
iu/ml
432.0
223.5
—
5
31
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
49
349
1.42
1.53
1.5
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
452
1.36
1.52
2.9
2.5
g/l
3.0
3.1
0.48
51
358
(3019309) Folate [Moles/volume] in Red Blood Cells
264
2319
1.17
1.49
1.9
1.8
nmol/l
1093.7
1186.3
1.03
210
1734
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
125
1515
0.81
1.49
4.4
4.5
%
30.9
32.1
0.57
96
1012
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
72
1.95
1.49
1.1
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
23
139
1.67
1.48
1.3
1.4
pmol/l
188.2
297.5
2.23
18
111
(3037522) Nuclear Ab [Titer] in Serum
182
1550
1.20
1.48
1.5
1.3
titre
532.5
515.8
0.05
48
334
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
47
335
1.42
1.47
2.8
2.3
%
185.9
191.9
0.16
42
317
(3021440) Promyelocytes/100 leukocytes in Blood
117
953
1.25
1.46
4.4
4.4
%
0.1
0.1
0.25
42
279
(3000475) Leukocytes [#/volume] in Synovial fluid
43
302
1.44
1.46
1.4
1.6
e6/l
35601.8
16997.5
0.63
22
219
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
140
1164
1.22
1.45
2.5
2.2
g/l
0.2
0.2
2.12
133
1092
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
115
936
1.25
1.45
4.4
3.8
ng/l
93.3
89.9
0.14
102
824
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
482
1.34
1.45
2.8
2.5
g/l
3.4
3.8
1.80
51
351
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
125
1.69
1.44
1.0
1.0
u/ml
6.5
3.2
—
10
48
(3051611) Lipemic interference index of Serum or Plasma
21
125
1.69
1.44
2.4
3.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
6
22
2.73
1.43
1.0
1.0
u/ml
116.2
30.1
—
6
22
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
483
1.34
1.43
2.8
2.5
g/l
7.1
7.4
0.45
51
367
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
483
1.34
1.43
2.8
2.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
24
149
1.62
1.41
1.6
1.3
mu/l
67.1
44.4
0.26
19
134
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
29
2.42
1.39
1.4
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
45
322
1.41
1.39
1.6
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
50
366
1.38
1.36
2.5
2.1
%
89.4
90.2
0.07
45
349
(3005011) Chlamydia sp Ab [Titer] in Serum
5
17
2.95
1.36
2.0
1.6
—
—
—
0
0
(4094501)
47
341
1.39
1.35
1.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
47
2.14
1.33
1.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
90
1.79
1.33
1.4
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
276
2455
1.15
1.33
1.3
1.2
u/ml
1.3
1.6
0.29
69
642
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
515
4770
1.12
1.33
4.2
3.7
ng/l
160.3
49.6
0.42
351
3423
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
39
276
1.42
1.29
1.6
1.9
iu/l
2.9
5.3
2.30
15
93
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
54
405
1.35
1.28
3.7
3.6
mg/l
36.1
71.2
0.57
40
329
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
92
743
1.25
1.27
1.9
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
46
337
1.38
1.26
1.3
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
401
3673
1.13
1.24
3.5
3.3
mg/l
939.9
335.2
0.99
268
2368
(3029937) Albumin [Presence] in Urine by Test strip
348
3163
1.13
1.22
4.8
4.0
estimate
0.0
0.0
0.69
129
1083
(3006184) Hemoglobin [Mass/volume] in Capillary blood
37
263
1.42
1.21
1.5
2.3
g/l
133.7
129.4
0.42
24
203
(3051651) Icteric interference index of Serum or Plasma
14
78
1.80
1.21
1.9
3.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
174
1507
1.18
1.19
1.4
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
54
411
1.33
1.18
3.5
2.7
g/l
1.0
1.3
0.48
47
364
(3009508) Creatinine [Moles/volume] in Urine
422
3889
1.12
1.17
3.3
3.2
mmol/l
7.2
7.7
1.51
362
3260
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
223
1.44
1.17
1.3
1.5
—
—
—
0
0
(3013512) EKG study
394
3619
1.12
1.16
3.9
3.9
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
56
430
1.31
1.16
1.8
1.7
mg/l
2.4
4.2
0.73
45
311
(3034860) Kappa light chains.free [Mass/volume] in Serum
53
404
1.32
1.15
3.8
3.6
mg/l
42.6
66.2
0.76
39
327
(3036489) Thrombin time
58
448
1.31
1.15
2.3
2.0
s
20.9
21.6
0.54
47
403
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
15
87
1.73
1.15
2.2
1.5
g/l
1.0
1.0
0.02
15
87
(44813793)
13
72
1.81
1.15
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
13
73
1.79
1.11
2.1
2.0
%
13.4
16.2
—
8
29
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
28
193
1.46
1.09
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
42
313
1.35
1.07
1.1
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
74
1.76
1.07
1.5
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
178
1.47
1.05
1.3
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
82
1.71
1.05
1.9
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
179
1.46
1.03
1.3
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
28
196
1.44
1.02
1.1
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
10
53
1.89
1.01
1.0
1.2
iu/ml
151.6
227.5
—
10
53
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
91
1.66
1.00
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
21
139
1.52
1.00
1.4
2.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
19
123
1.55
0.99
3.7
2.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
261
0.65
0.99
5.9
3.8
mg/l
25.9
27.0
—
10
170
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
48
371
1.30
0.98
1.6
1.9
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
36
1.95
0.97
1.1
1.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
16
100
1.61
0.97
2.1
2.1
e9/l
1.1
1.1
—
9
57
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
23
157
1.47
0.96
1.3
1.0
u/ml
1.2
2.3
1.27
14
63
(3008152) Bicarbonate [Moles/volume] in Arterial blood
95
798
1.20
0.96
6.6
7.7
mmol/l
24.9
24.5
0.52
87
747
(3025159) Blasts/100 leukocytes in Blood
106
900
1.19
0.95
4.4
4.5
%
0.0
0.5
0.64
33
240
(3020682) Albumin/Creatinine [Ratio] in Urine
418
3892
1.10
0.95
4.3
4.0
mg/mmol
6.5
8.9
0.90
277
2487
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
172
1520
1.15
0.94
10.1
7.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
11
62
1.78
0.94
1.4
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
41
312
1.32
0.94
1.2
1.1
u/ml
0.7
7.6
—
9
29
(3044927) Protein electrophoresis panel - Urine
8
146
0.55
0.92
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
55
1.82
0.92
4.3
3.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
85
1010
0.83
0.90
1.3
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
29
2.07
0.89
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
142
1244
1.16
0.89
1.6
1.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
42
1.91
0.88
2.6
1.9
ug/l
136.0
53.8
—
8
42
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
56
1.79
0.88
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
64
523
1.23
0.86
2.1
2.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
220
1990
1.12
0.86
1.3
1.3
iu/ml
22.8
32.6
1.23
57
635
(3045142) Bone marrow Pathology biopsy report
21
145
1.45
0.85
1.1
1.3
—
—
—
0
0
(3036603) Volume of Urine
13
80
1.63
0.84
1.5
1.4
ml
2501.3
1865.6
—
6
15
(3034426) Prothrombin time (PT)
6
32
1.88
0.82
1.0
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
198
1.37
0.80
1.3
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
23
164
1.41
0.80
1.2
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
17
114
1.50
0.79
1.1
1.1
u/ml
5.7
4.2
—
10
44
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
3.6
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
2.0
—
1.0
—
0
16
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
211
0.66
0.78
1.5
3.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
74
1.63
0.78
1.5
1.6
—
—
—
0
0
(4281824)
7
122
0.57
0.78
1.4
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
98
0.51
0.78
2.0
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
28
208
1.35
0.77
1.6
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
39
305
1.29
0.77
1.4
1.2
u/ml
19.1
8.8
—
5
47
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
115
1.48
0.77
2.2
2.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
17
115
1.48
0.77
1.5
1.9
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
0
28
0.00
0.76
0.0
3.4
—
14.8
—
0
23
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
59
1.70
0.76
2.2
2.9
u/ml
1037.3
1478.6
—
10
59
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
32
245
1.31
0.74
1.5
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
108
1.49
0.73
1.1
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
21
150
1.41
0.73
1.5
1.5
%
81.7
62.4
1.92
13
101
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
63
525
1.21
0.73
2.1
2.0
ug/l
6.0
1.8
0.75
58
465
(3018572) Chloride [Moles/volume] in Blood
37
290
1.28
0.73
6.3
9.0
mmol/l
103.4
105.6
1.30
32
263
(3039000) Anion gap in Blood
37
290
1.28
0.73
6.2
9.0
mmol/l
12.3
11.3
0.43
32
263
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
38
299
1.28
0.72
1.4
1.2
u/ml
1.8
2.5
—
5
28
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
142
1.41
0.72
1.8
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
340
3178
1.09
0.72
1.4
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
241
2615
0.91
0.71
1.8
1.7
pmol/l
66019853.9
28798190.3
0.36
206
2146
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
57
1.58
0.71
1.0
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
26
1.93
0.70
1.0
1.1
nmol/l
47.8
34.1
—
5
21
(40760888) Immunoglobulin light chains.free panel - Serum
38
301
1.27
0.69
4.3
3.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
54
446
1.22
0.69
2.1
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
116
1024
1.14
0.69
3.9
3.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
27
1.85
0.68
1.2
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
29
222
1.31
0.68
1.5
1.3
u/ml
111.6
127.8
—
7
38
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
7
118
0.59
0.68
1.3
1.4
nmol/l
1.2
1.4
—
7
106
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
102
1.48
0.67
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
153
1.38
0.67
1.4
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
130
0.61
0.63
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
155
1.36
0.63
1.4
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
155
1.36
0.63
1.4
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
48
397
1.22
0.62
1.1
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
17
121
1.41
0.62
3.2
3.7
%
59.9
52.2
—
8
88
(3047189) Immunofixation for 24 hour Urine
10
63
1.59
0.62
1.2
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
63
1.59
0.62
5.9
7.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
55
464
1.19
0.59
1.9
2.3
ug/l
910.8
446.9
0.42
49
441
(3019150) Specific gravity of Urine by Refractometry
274
2562
1.09
0.59
5.1
4.0
kg/l
1.0
1.0
1.56
38
377
(3037756) Immunofixation for Serum or Plasma
35
282
1.25
0.58
1.5
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
17
123
1.39
0.58
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
158
1441
1.11
0.57
1.6
1.8
%
1.5
1.5
0.11
128
1246
(3015183) Erythrocyte sedimentation rate
8
55
1.46
0.56
1.1
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
25
194
1.29
0.56
3.2
3.7
%
0.8
1.5
0.89
15
160
(4015189)
6
37
1.62
0.55
1.0
2.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
61
1.48
0.53
2.3
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
160
1.32
0.53
1.8
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
152
1.32
0.52
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
152
1.32
0.52
1.5
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
64
1.41
0.51
1.3
3.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
426
1.18
0.50
2.2
2.6
u/ml
0.3
0.3
0.42
23
238
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
65
1.39
0.50
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
65
1.39
0.50
1.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
20
153
1.31
0.50
1.3
2.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
153
1.31
0.50
1.5
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.49
1.7
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.49
1.7
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.49
1.7
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.49
1.7
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
42
353
1.20
0.49
2.0
1.8
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
21
268
0.78
0.49
5.0
3.3
mmol/l
8.2
7.5
0.55
21
262
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
486
4670
1.06
0.49
5.0
4.8
ug/l
2.4
2.7
0.45
431
4183
(3043410) Blood group antigens tested for on Red Blood Cells
7
45
1.56
0.49
1.9
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
110
1.37
0.49
1.5
1.4
%
20.7
30.3
—
9
71
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
58
667
0.86
0.48
1.4
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
46
1.52
0.48
1.1
1.2
—
17.1
—
0
7
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
392
3744
1.06
0.48
4.1
4.2
%
23.2
21.4
1.42
182
1788
(3036071) Salmonella sp Ab [Titer] in Serum
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
318
1.20
0.47
1.7
2.4
ug/min
114.4
93.8
0.18
18
191
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
32
263
1.22
0.47
1.2
2.0
nmol/l
0.9
0.8
0.07
26
220
(3000330) Specific gravity of Urine by Test strip
70
617
1.14
0.47
4.2
3.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
12
85
1.42
0.47
3.0
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
468
4500
1.06
0.46
4.7
3.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
37
310
1.20
0.46
1.6
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
11
77
1.43
0.45
2.5
2.6
%
32.2
42.2
—
5
24
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
60
525
1.15
0.45
5.2
6.3
%
1.8
1.6
0.54
54
493
(3022621) pH of Urine by Test strip
87
782
1.12
0.44
3.0
2.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
51
1.37
0.44
1.1
1.5
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
13
95
1.37
0.43
1.0
1.1
—
43.4
—
0
5
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
23
285
0.80
0.43
1.5
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
140
0.71
0.43
1.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
91
0.66
0.42
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
16
122
1.31
0.42
1.9
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
140
1.29
0.42
1.6
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
405
4214
0.95
0.42
2.9
2.9
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
13
96
1.36
0.41
1.0
1.1
—
61.9
—
0
8
(44806071)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
47.5
—
0
15
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
16
0.00
0.41
0.0
2.8
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.7
—
0
11
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
16
0.00
0.41
0.0
2.8
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
16
0.00
0.41
0.0
1.4
—
6.2
—
0
11
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
(3000012) Reticulocyte production index
8
60
1.34
0.40
1.3
1.9
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
10
71
1.41
0.39
2.1
1.6
u/field
0.9
5.3
—
10
52
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
59
524
1.13
0.38
5.2
6.3
%
0.9
0.9
0.12
54
493
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
9
68
1.33
0.37
1.2
1.3
—
69.0
—
0
10
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
91
996
0.91
0.37
1.6
1.8
—
—
—
0
0
(3020891) Body temperature
57
506
1.13
0.37
4.3
4.6
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
37
1.35
0.37
1.0
1.1
pmol/l
211.2
294.0
—
5
24
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
71
1.27
0.36
1.3
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
71
1.27
0.36
1.1
3.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
27
226
1.20
0.36
1.8
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
76
0.66
0.35
1.0
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
273
1.18
0.35
1.5
1.4
e6/l
32.1
41.8
0.13
25
211
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
273
1.18
0.35
1.5
1.5
e6/l
21461.0
836.9
0.53
26
220
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
126
0.71
0.35
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
45
1.33
0.33
1.0
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
31
265
1.17
0.33
2.0
1.9
pmol/l
204.5
217.0
0.23
31
249
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
100
1.30
0.33
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
16
127
1.26
0.33
1.9
1.6
—
—
—
0
0
(4306422)
21
173
1.22
0.33
1.3
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
42
369
1.14
0.33
1.5
1.6
iu/ml
0.5
19.8
—
8
61
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
47
1.28
0.32
1.2
1.3
—
—
—
0
0
(3019225) pH of Specimen
112
1203
0.93
0.32
4.8
4.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
33
286
1.16
0.31
2.7
3.2
umol/l
30.2
34.6
0.66
26
237
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
282
2708
1.05
0.31
3.0
3.0
ug/l
0.8
0.7
0.57
188
1782
(3027944) Amphetamines [Presence] in Urine
39
344
1.14
0.29
1.3
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
39
344
1.14
0.29
1.3
2.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
31
269
1.16
0.29
1.5
2.2
—
—
—
0
0
(4024509)
8
107
0.75
0.29
1.1
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
39
345
1.13
0.28
1.3
2.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
23
270
0.85
0.28
1.7
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
79
729
1.09
0.28
1.1
1.2
iu/ml
73.9
139.7
1.81
33
287
(3028300) Cannabinoids [Presence] in Urine
39
346
1.13
0.28
1.3
1.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
85
790
1.08
0.26
3.3
3.2
e9/l
4.0
4.1
0.07
72
611
(3027923) C peptide [Moles/volume] in Serum or Plasma
8
67
1.20
0.26
1.0
1.3
nmol/l
1.5
1.1
—
8
53
(3032773) Endomysium IgG Ab [Titer] in Serum
12
95
1.27
0.26
1.0
1.1
titre
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
141
1.21
0.26
1.4
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
73
0.68
0.26
43.0
19.6
nmol/l
1570.0
1492.6
—
5
73
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
72
1.25
0.25
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
123
1.22
0.25
1.9
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
26
226
1.15
0.25
1.4
3.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
28
245
1.15
0.24
1.5
1.5
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
6
81
0.74
0.24
2.0
2.1
ug/l
1.0
1.9
—
6
69
(3017704) Immunofixation for Urine
6
82
0.73
0.24
2.3
1.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
6
82
0.73
0.24
2.0
2.0
ug/l
2.3
3.0
—
6
72
(3023199) Leukocytes [#/volume] in Pleural fluid
18
152
1.19
0.23
1.7
1.4
e6/l
625.4
1617.6
3.07
11
106
(3035880) pH of Pleural fluid
10
79
1.27
0.22
1.1
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
267
1.13
0.21
1.3
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
107
1.22
0.21
1.0
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
107
1.22
0.21
1.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
173.2
—
0
5
(44806420)
5
43
1.16
0.21
2.8
2.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
177
0.85
0.21
1.4
1.5
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.0
—
0
6
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
76
810
0.93
0.20
4.1
3.6
ph
7.4
7.4
—
9
112
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
95.3
—
0
14
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
16
136
1.18
0.20
1.8
1.4
e6/l
44158.6
73498.7
—
7
79
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
77
819
0.94
0.20
4.2
3.6
kpa
5.1
5.1
0.05
72
766
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
115
0.78
0.20
1.1
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
197
0.86
0.19
1.2
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
54
582
0.93
0.19
5.4
3.7
%
51.6
49.0
0.33
54
574
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
33
298
1.11
0.19
1.7
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
21
184
1.14
0.19
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
21
184
1.14
0.19
1.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
52
1.15
0.19
1.8
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
52
1.15
0.19
1.8
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
53
1.13
0.18
1.8
2.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
128
1.17
0.18
4.9
2.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
22
248
0.89
0.18
1.4
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
227
0.88
0.18
1.1
1.3
—
—
—
0
0
(44790047)
16
138
1.16
0.17
1.6
1.5
—
—
—
0
0
(44790049)
16
138
1.16
0.17
1.6
1.5
—
—
—
0
0
(44806118)
16
138
1.16
0.17
1.6
1.5
—
—
—
0
0
(44790048)
16
138
1.16
0.17
1.6
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
16
184
0.87
0.17
1.3
1.2
u/ml
2.0
4.5
—
5
57
(3016879) Cocaine [Presence] in Urine
35
320
1.10
0.17
1.3
2.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
82
1.22
0.17
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
82
1.22
0.17
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
82
1.22
0.17
1.4
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
30
330
0.91
0.17
6.6
4.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
186
1.13
0.17
1.8
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
57
534
1.07
0.16
1.1
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
55
587
0.93
0.16
4.8
3.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
38
350
1.09
0.16
1.2
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
70
1.14
0.16
1.1
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
162
0.86
0.16
3.4
2.6
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
83
1.21
0.15
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
83
1.21
0.15
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
83
1.21
0.15
1.4
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
9
78
1.15
0.15
1.2
1.3
ug/l
3.1
2.5
—
9
62
(3027456) Digoxin [Moles/volume] in Serum or Plasma
29
265
1.10
0.14
2.5
3.1
nmol/l
0.9
0.8
0.07
24
208
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
89
0.79
0.14
1.0
1.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
7
90
0.78
0.14
1.3
1.3
u/l
13.3
13.8
—
7
84
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
41
382
1.08
0.14
1.9
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
66
627
1.06
0.13
1.3
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
159
0.88
0.13
1.1
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
32
345
0.93
0.13
3.4
2.8
mmol/l
24.8
24.8
0.03
27
302
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
33
306
1.08
0.13
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
43
404
1.07
0.12
1.5
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
85
1.18
0.12
1.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
80
768
1.04
0.11
1.5
1.6
—
—
—
0
0
(4146454)
11
126
0.87
0.11
3.2
2.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
125
1.12
0.10
1.9
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
44
1.14
0.10
1.0
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
132
1286
1.03
0.10
3.6
4.3
ug/l
67.2
23.0
0.33
106
1060
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
21
193
1.09
0.10
1.6
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
45
1.11
0.09
1.8
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
176
0.91
0.09
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
13
116
1.12
0.09
1.3
1.5
nmol/l
0.3
0.3
—
8
90
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
233
1.07
0.09
1.1
1.2
u/ml
189.5
275.7
1.01
13
140
(3041096) Erythrocytes [Presence] in Urine by Automated
322
3177
1.02
0.09
3.7
3.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
134
0.89
0.08
1.3
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
58
1.03
0.08
2.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
58
1.03
0.08
2.5
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
61
0.82
0.08
1.0
1.3
ug/l
3.4
5.8
—
5
51
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
62
0.81
0.08
6.0
3.2
—
—
—
0
0
(4034850)
36
379
0.95
0.08
15.9
10.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
117
1.11
0.08
1.6
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
65
1.08
0.08
2.0
1.3
nmol/l
128.9
145.0
—
7
65
(40757494) Bilirubin.total [Moles/volume] in Blood
7
67
1.04
0.08
2.4
1.9
—
48.3
—
0
5
(3021901) Oxygen saturation in Capillary blood
26
246
1.06
0.06
2.3
2.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
131
0.92
0.05
1.2
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
47
455
1.03
0.05
1.9
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
110
1.09
0.05
1.7
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
248
1.05
0.05
1.1
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
44
454
0.97
0.04
2.0
3.5
g/l
0.2
0.3
0.30
16
190
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
76
776
0.98
0.04
3.6
3.5
mmol/l
1.6
1.8
0.22
51
575
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
140
1.07
0.04
2.7
4.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
27
281
0.96
0.04
1.5
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
131
1.07
0.03
1.4
2.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
24
230
1.04
0.03
1.8
2.3
u/l
3616.4
3376.4
—
7
94
(3001019) Free T4 and TSH panel - Serum or Plasma
52
508
1.02
0.03
1.4
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
128
0.94
0.02
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
123
1.06
0.01
1.5
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
49
483
1.01
0.01
3.3
3.4
u/ml
12632.4
3087.4
0.34
42
408
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
104
1.06
0.01
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
136
0.96
0.00
1.8
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
206
0.97
0.00
1.4
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
28
286
0.98
0.00
1.1
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
114
0.96
0.00
1.1
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
12
116
1.03
0.00
1.3
2.1
—
1.6
—
0
6
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
116
1.03
0.00
1.6
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
116
1.03
0.00
1.6
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
116
1.03
0.00
1.6
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
136
1.03
0.00
1.4
1.8
—
—
—
0
0
(4268621)
12
118
1.02
0.00
2.1
2.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
49
494
0.99
0.00
4.4
4.0
mmol/l
24.6
24.9
0.27
44
465
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
152
0.99
0.00
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
152
0.99
0.00
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
152
0.99
0.00
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
152
0.99
0.00
1.3
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
292
0.99
0.00
1.5
1.3
miu/ml
241.6
227.5
0.07
14
131
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
183
0.98
0.00
1.3
1.2
u/ml
2.1
6.4
—
8
79
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
49
493
0.99
0.00
2.2
1.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
17
165
1.03
0.00
1.2
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
125
0.96
0.00
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
125
0.96
0.00
1.2
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.0
—
38.9
—
0
8
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.0
—
21.3
—
0
8
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
69
1.01
0.00
2.3
1.4
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.0
—
7.5
—
0
8
(3025315) Body weight
0
8
0.00
0.00
0.0
3.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
69
1.01
0.00
2.3
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
6
69
0.87
0.00
1.2
6.5
—
69.3
—
0
18
(3016038) Potassium [Moles/volume] in Urine
8
82
0.98
0.00
2.3
1.1
mmol/l
40.5
34.5
—
8
76
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
63
0.95
0.00
1.5
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
60
1.00
0.00
1.0
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.3
—
0
5
(3011048) Pyruvate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
85.6
—
0
7
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
6
0.00
0.00
0.0
1.2
—
7.5
—
0
6
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
5
0.00
0.00
0.0
2.4
—
168.2
—
0
5
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.2
—
0
6
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.5
—
0
6
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
8
87
0.92
0.00
1.5
1.5
—
73.5
—
0
6
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
9
98
0.92
0.00
1.1
1.1
nmol/l
450.3
380.5
—
9
84
(3013862) HLA-DP [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
13
130
1.00
0.00
1.1
1.3
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
7
74
0.95
0.00
1.4
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.6
—
403.1
—
0
7
(46236302) HLA-C [Type] by High resolution typing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
7
74
0.95
0.00
1.3
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
6
67
0.90
0.00
1.7
2.0
mmol/l
9.3
9.7
—
6
54
(3036525) Urea [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
15.2
—
0
7
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_EAR_NASAL_SINUS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_EAR_NASAL_SINUS | 1.289 [1.13, 1.47] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.221 |
During the follow-up period (1.1.1998 — 31.12.2019), 531 out of 3276 females with CD2_BENIGN_EAR_NASAL_SINUS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_EAR_NASAL_SINUS | 1.197 [0.99, 1.44] | 0.058 |
| Birth year | 0.989 [0.94, 1.04] | 0.691 |
During the follow-up period (1.1.1998 — 31.12.2019), 689 out of 3623 males with CD2_BENIGN_EAR_NASAL_SINUS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_EAR_NASAL_SINUS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.15% | 0.216% |
| 5 | 0.85% | 1.352% |
| 10 | 2.003% | 3.63% |
| 15 | 3.69% | 6.902% |
| 20 | 6.21% | 11.55% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_EAR_NASAL_SINUS – Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data